Comments
Loading...
Orientation et prévision
ANI Pharmaceuticals publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/08/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | $6.98 | $7.35 | $5.97 | $818.00M | $843.00M | $790.83M | |
06/04/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | $6.27 | $6.62 | $6.34 | $768.00M | $793.00M | $769.62M | |
05/09/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | $6.27 | $6.62 | $6.34 | $768.00M | $793.00M | $769.64M | |
02/28/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | $6.12 | $6.49 | $5.56 | $756.00M | $776.00M | $724.88M | |
01/13/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | — | — | — | $739.00M | $759.00M | $720.30M | |
11/08/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.90 | $5.05 | $4.72 | $594.00M | $602.00M | $590.31M | |
08/06/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.38 | $4.82 | $4.49 | $540.00M | $560.00M | $554.60M | |
05/14/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | — | — | — | $520.00M | $542.00M | $513.14M | |
05/10/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.48 | $520.00M | $542.00M | $535.11M | |
04/17/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.47 | $520.00M | $542.00M | $534.15M | |
03/12/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.46 | $520.00M | $542.00M | $535.28M | |
02/29/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.33 | $520.00M | $542.00M | $501.09M | |
11/08/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $4.29 | $4.57 | $4.08 | $468.00M | $478.00M | $452.94M | |
09/12/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.97 | $425.00M | $445.00M | $442.97M | |
08/30/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.97 | $425.00M | $445.00M | $442.97M | |
08/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.31 | $425.00M | $445.00M | $406.41M | |
06/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | — | — | — | $385.00M | $410.00M | $403.52M | |
05/08/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $2.99 | $3.45 | $2.43 | $385.00M | $410.00M | $361.82M | |
03/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $2.09 | $2.59 | $2.62 | $360.00M | $385.00M | $352.49M | |
11/09/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.37 | $295.00M | $315.00M | $302.88M | |
08/08/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.43 | $295.00M | $315.00M | $304.50M | |
05/10/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.15 | $295.00M | $315.00M | $292.77M | |
03/15/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | — | — | — | $260.00M | $275.00M | $301.57M |
FAQ
Quelles sont les dernières directives pour ANI Pharmaceuticals (ANIP) ?
Les dernières prévisions pour ANI Pharmaceuticals (ANIP) ont été communiquées le août 8, 2025 pour l'année complète 2025. L'entreprise a fourni des prévisions de bénéfice par action dans une fourchette de $6.98 à $7.35, par rapport à un BPA estimé de $5.97. De plus, ANI Pharmaceuticals a prévu un chiffre d'affaires entre $0.82B et $0.84B pour le trimestre.
Parcourir guidance et prévisions sur toutes les actions.